PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,653 Cr | ₹892 Cr | ₹1,005 Cr | ₹484 Cr | ₹766 Cr |
What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,653 Cr |
| Mar2025 | ₹892 Cr |
| Mar2024 | ₹1,005 Cr |
| Mar2023 | ₹484 Cr |
| Mar2022 | ₹766 Cr |
How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,653 Cr | 85.21 | |
| Mar2025 | ₹892 Cr | -11.17 | |
| Mar2024 | ₹1,005 Cr | 107.60 | |
| Mar2023 | ₹484 Cr | -36.86 | |
| Mar2022 | ₹766 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹25,567.6 Cr | 1.2% | 5% | -16.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 1.2% |
5% |
-16.5% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses